The role of sodium bisulfite in the 1996-1997 USA influenza vaccine recall

Gregory A. Poland

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

During the 1996-1997 influenza season, all the lots of influenza vaccine manufactured by Parke-Davis were recalled. This voluntary recall by the manufacturer was prompted by the finding of decreasing potency of the A/Nanchang/933/95 (H3N2) component of the vaccine. The primary cause of this lowered potency has been identified as primarily due to the presence of sodium bisulfite which was used to neutralize residual formaldehyde which in tutor is used to inactivate the live influenza vaccine strains. This paper reviews these events and what we have learned.

Original languageEnglish (US)
Pages (from-to)1865-1868
Number of pages4
JournalVaccine
Volume16
Issue number19
DOIs
StatePublished - Nov 1998

Fingerprint

sodium bisulfite
Influenza Vaccines
influenza
vaccines
Human Influenza
Formaldehyde
Vaccines
formaldehyde

ASJC Scopus subject areas

  • Immunology
  • Microbiology
  • Virology
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)

Cite this

The role of sodium bisulfite in the 1996-1997 USA influenza vaccine recall. / Poland, Gregory A.

In: Vaccine, Vol. 16, No. 19, 11.1998, p. 1865-1868.

Research output: Contribution to journalArticle

Poland, Gregory A. / The role of sodium bisulfite in the 1996-1997 USA influenza vaccine recall. In: Vaccine. 1998 ; Vol. 16, No. 19. pp. 1865-1868.
@article{eecd05fbf1f247dcb91cbe24db1c2800,
title = "The role of sodium bisulfite in the 1996-1997 USA influenza vaccine recall",
abstract = "During the 1996-1997 influenza season, all the lots of influenza vaccine manufactured by Parke-Davis were recalled. This voluntary recall by the manufacturer was prompted by the finding of decreasing potency of the A/Nanchang/933/95 (H3N2) component of the vaccine. The primary cause of this lowered potency has been identified as primarily due to the presence of sodium bisulfite which was used to neutralize residual formaldehyde which in tutor is used to inactivate the live influenza vaccine strains. This paper reviews these events and what we have learned.",
author = "Poland, {Gregory A.}",
year = "1998",
month = "11",
doi = "10.1016/S0264-410X(98)00184-4",
language = "English (US)",
volume = "16",
pages = "1865--1868",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "19",

}

TY - JOUR

T1 - The role of sodium bisulfite in the 1996-1997 USA influenza vaccine recall

AU - Poland, Gregory A.

PY - 1998/11

Y1 - 1998/11

N2 - During the 1996-1997 influenza season, all the lots of influenza vaccine manufactured by Parke-Davis were recalled. This voluntary recall by the manufacturer was prompted by the finding of decreasing potency of the A/Nanchang/933/95 (H3N2) component of the vaccine. The primary cause of this lowered potency has been identified as primarily due to the presence of sodium bisulfite which was used to neutralize residual formaldehyde which in tutor is used to inactivate the live influenza vaccine strains. This paper reviews these events and what we have learned.

AB - During the 1996-1997 influenza season, all the lots of influenza vaccine manufactured by Parke-Davis were recalled. This voluntary recall by the manufacturer was prompted by the finding of decreasing potency of the A/Nanchang/933/95 (H3N2) component of the vaccine. The primary cause of this lowered potency has been identified as primarily due to the presence of sodium bisulfite which was used to neutralize residual formaldehyde which in tutor is used to inactivate the live influenza vaccine strains. This paper reviews these events and what we have learned.

UR - http://www.scopus.com/inward/record.url?scp=0032210721&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032210721&partnerID=8YFLogxK

U2 - 10.1016/S0264-410X(98)00184-4

DO - 10.1016/S0264-410X(98)00184-4

M3 - Article

C2 - 9795393

AN - SCOPUS:0032210721

VL - 16

SP - 1865

EP - 1868

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 19

ER -